MediSys: new alerting tool for the EU
This article was originally published in Clinica
There is a new tool in the EU armoury intended to safeguard public health which will provide an early alert of issues that may impact the medical devices industry or have implications for the use of or need for medical devices and diagnostics. The European Commission has just launched MediSys, a medical intelligence system that constantly collects and sorts information from more than 1,000 news and 120 public health websites in 32 languages.
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.